Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ginsenoside Rh1
Cat. No.:
0225LY-0780
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Ginsenoside Rh1 is a primary active constituent of Panax ginseng known for its anti-inflammatory effects.
Synonym:
Sanchinoside B2; Prosapogenin A2; 20(S)-Ginsenoside Rh1; Sanchinoside Rh1; 63223-86-9; 20(S)-Ginsenoside Rh1; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,10R,12R,14R,17S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
CAS No.:
63223-86-9
Compound CID:
12855920
Formula:
C36H62O9
Formula Weight:
638.87
Specification
Relative Density:
1.23 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ginsenoside Rh1 can be used in pharmacology to study the anti-inflammatory and neuroprotective effects of ginsenoside metabolites.
Library Information
Target:
IL receptor; PPAR; Interleukin; TNF
Receptor:
IL receptor; Interleukin; PPAR; TNF receptor
Pathways:
DNA damage/DNA repair; Apoptosis; Immunology/Inflammation; Metabolism
Plate Number:
AOCL-11
Plate Location:
a9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 93.92 mM
